TheProfitWatch

RNA - Avidity Biosciences, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
70.7 -0.02 (-0.03%) -0.02 (-0.03%) -0.06 (-0.08%) -0.04 (-0.06%) 0.09 (0.13%) 0.01 (0.01%) --- 0.09 (0.13%)

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.21
Diluted EPS:
-1.21
Basic P/E:
-58.4132
Diluted P/E:
-58.4132
RSI(14) 1m:
61.36
VWAP:
70.69
RVol:

Events

Period Kind Movement Occurred At

Related News